At day 21 post-initiation of bintrafusp alfa treatment, there was a linear relationship between the percentage of PD-1+ CD8+ T cells in the spleen and the tumor mass in bintrafusp alfa-treated animals (linear regression, R2 = 0.46; Figure 7A). The gene discussed is CD8A; the disease is neoplasm.